Skip to content
ppharmaranks
Menu

Best Carbonic Anhydrase Inhibitor for glaucoma, open-angle

Top-rated pick: Dorzolamide Hydrochloride — pharmaranks score 70/100, the highest of the 2 Carbonic Anhydrase Inhibitor drugs used for glaucoma, open-angle, ranked by our independent FDA recall-safety score. Compare them with all treatments for glaucoma, open-angle or the full Carbonic Anhydrase Inhibitor class. Not medical advice — always consult a professional.

Quick answer: Of the 2 carbonic anhydrase inhibitor drugs we rate for glaucoma, open-angle, all are available as lower-cost generics, and most are solution. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for glaucoma, open-angle; the right choice depends on your situation, so confirm it with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

How carbonic anhydrase inhibitor work

These block the enzyme carbonic anhydrase, which normally helps the body recycle bicarbonate. In the kidneys this flushes more bicarbonate, sodium, and water into the urine, and in the eye it cuts production of the fluid that builds up pressure, which is why they treat conditions like glaucoma and altitude sickness.

Source: Carbonic Anhydrase Inhibitors - StatPearls - NCBI Bookshelf

Top carbonic anhydrase inhibitor for glaucoma, open-angle: 1. Dorzolamide Hydrochloride · 2. Azopt

Best-rated Carbonic Anhydrase Inhibitor for glaucoma, open-angle, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$1View →
268/100$10View →

Full ranking · 2 drugs

Frequently asked

What is the best carbonic anhydrase inhibitor for glaucoma, open-angle?
By our independent recall-safety rating — not an efficacy measure — dorzolamide hydrochloride ranks highest among Carbonic Anhydrase Inhibitor drugs used for glaucoma, open-angle. Always consult a professional.
Which carbonic anhydrase inhibitor drugs treat glaucoma, open-angle?
pharmaranks lists 2 Carbonic Anhydrase Inhibitor products used for glaucoma, open-angle, per NIH RxClass drug-classification data — each independently rated and ranked above.
How are these ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.